|
|
Article: Company files for IDE for rapid HIV test.(investigational device exemption)(Brief Article)
- Article from:
- Medical Laboratory Observer
- Article date:
- July 1, 2000
CopyrightCOPYRIGHT 2000 Nelson Publishing. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Epitope, Inc. (Beaverton, OR), which markets the OraQuick rapid oral-fluid or blood test for HIV, has filed for an investigational device exemption for the test with the FDA. The assay, which can provide results with 20 ...
Related newspaper, magazine, and journal articles:
|
|
Article: Investigational Device Exemption Application ...
Blood Weekly;
November 19, 2009 ;
700+ words
... ... 8482; Total Artificial Heart, announced it has submitted an application to the FDA to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ discharge driver, designed to power the Total Artificial ...
|
|